Autoimmunity After Checkpoint Blockade

Clinical trial NCT04119713 · RECRUITING

Trial details

NCT number: NCT04119713
Sponsor: Abramson Cancer Center at Penn Medicine
Status: RECRUITING
Study type: OBSERVATIONAL

Autoimmunity Cancer Immunotoxicity Oncology

Start date: 2020-02-24
Primary completion: 2026-06-30
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.